Wyniki wyszukiwania:

Bachelorarbeit aus dem Jahr 2015 im Fachbereich Sport - Sportokonomie, Sportmanagement, Note: 1,5, Deutsche Sporthochschule Koln (Institut fur Sportokonomie und Sportmanagement), Sprache: Deutsch, Abstract: Im Rahmen dieser Arbeit soll gepruft werden, ob der CSR (Corporate Social Responsibility)-Ansatz fur das Sportsponsoring Gultigkeit besitzt, da Sportsponsoring in jedem Fall eine Geschaftstatigkeit der sponsernden Unternehmen darstellt. Die zentrale Thematik liegt nun in der Ubertragung und Umsetzung des Managementansatzes CSR auf das Sportsponsoring. Es stellt sich die Frage, ob ein...

This is an EXACT reproduction of a book published before 1923. This IS NOT an OCR'd book with strange characters, introduced typographical errors, and jumbled words. This book may have occasional imperfections such as missing or blurred pages, poor pictures, errant marks, etc. that were either part of the original artifact, or were introduced by the scanning process. We believe this work is culturally important, and despite the imperfections, have elected to bring it back into print as part of our continuing commitment to the preservation of printed works worldwide. We appreciate your...

Leading experts provide timely and comprehensive information on methods for conditional mutagenesis in the mouse (part 1) and their application to model human physiology and pathophysiology (part 2). It illustrates how sophisticated genetic manipulations of the mouse genome are employed to model human diseases and to identify underlying molecular mechanisms. Finally the book considers the development of new drugs to treat them.

Leading experts provide timely and comprehensive information on methods for conditional mutagenesis in the mouse (part 1) and their application to model human physiology and pathophysiology (part 2). It illustrates how sophisticated genetic manipulations of the mouse genome are employed to model human diseases and to identify underlying molecular mechanisms. Finally the book considers the development of new drugs to treat them.